| 1/2 | US=96 / Biol/Mol Dunn BK, Ryan A. Phase 3 trials of aromatase inhibitors for breast cancer prevention. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 141-61. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0. PREVENCAO DO CANCER DE MAMA; INIBIDOR DA AROMATASE; MODULADOR SELETIVO DO RECEPTOR DE ESTROGENIO; TAMOXIFENO; CANCER DE MAMA CONTRALATERAL; ARIMIDEX; TAMOXIFENO SOZINHO OU EM COMBINACAO; SERM; TAM; AI; CLBC; ATAC |
| 2/2 | US=47 / Clín/Medica Harkonen PL, Vaananen HK. Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 218-27. ISBN 978-1-57331-699-5. ESTROGENIO; RECEPTOR DE ESTROGENO; MODULADOR SELETIVO DO RECEPTOR DE ESTROGENO; OSTEOCLASTOS; CELULAS DENDRITICAS; MICROGLIA; MACROFAGOS ASSOCIADOS A TUMORES; CANCER DE MAMA; CANCER DE PROSTATA |